nodes	percent_of_prediction	percent_of_DWPC	metapath
Rasagiline—BCL2—epilepsy syndrome	0.276	1	CbGaD
Rasagiline—Parkinson's disease—Clonazepam—epilepsy syndrome	0.183	0.554	CpDpCtD
Rasagiline—Parkinson's disease—Gabapentin—epilepsy syndrome	0.148	0.446	CpDpCtD
Rasagiline—MAOB—Zonisamide—epilepsy syndrome	0.0942	0.515	CbGbCtD
Rasagiline—CYP1A2—Carbamazepine—epilepsy syndrome	0.0181	0.0986	CbGbCtD
Rasagiline—CYP1A2—Primidone—epilepsy syndrome	0.0169	0.092	CbGbCtD
Rasagiline—CYP1A2—Propofol—epilepsy syndrome	0.0151	0.0825	CbGbCtD
Rasagiline—CYP1A2—Phenobarbital—epilepsy syndrome	0.0144	0.0788	CbGbCtD
Rasagiline—CYP1A2—Diazepam—epilepsy syndrome	0.0137	0.0747	CbGbCtD
Rasagiline—CYP1A2—Valproic Acid—epilepsy syndrome	0.0108	0.0589	CbGbCtD
Rasagiline—BCL2—forebrain—epilepsy syndrome	0.00105	0.113	CbGeAlD
Rasagiline—MAOB—ganglion—epilepsy syndrome	0.00105	0.112	CbGeAlD
Rasagiline—BCL2—telencephalon—epilepsy syndrome	0.00097	0.104	CbGeAlD
Rasagiline—MAOB—hindbrain—epilepsy syndrome	0.000794	0.0849	CbGeAlD
Rasagiline—BCL2—head—epilepsy syndrome	0.000604	0.0646	CbGeAlD
Rasagiline—BCL2—nervous system—epilepsy syndrome	0.000573	0.0613	CbGeAlD
Rasagiline—BCL2—central nervous system—epilepsy syndrome	0.000551	0.059	CbGeAlD
Rasagiline—MAOB—brainstem—epilepsy syndrome	0.000455	0.0487	CbGeAlD
Rasagiline—MAOB—forebrain—epilepsy syndrome	0.000439	0.047	CbGeAlD
Rasagiline—BCL2—brain—epilepsy syndrome	0.000438	0.0468	CbGeAlD
Rasagiline—MAOB—telencephalon—epilepsy syndrome	0.000404	0.0432	CbGeAlD
Rasagiline—MAOB—medulla oblongata—epilepsy syndrome	0.000317	0.0339	CbGeAlD
Rasagiline—MAOB—midbrain—epilepsy syndrome	0.00029	0.031	CbGeAlD
Rasagiline—MAOB—spinal cord—epilepsy syndrome	0.000283	0.0303	CbGeAlD
Rasagiline—MAOB—head—epilepsy syndrome	0.000252	0.0269	CbGeAlD
Rasagiline—MAOB—nervous system—epilepsy syndrome	0.000238	0.0255	CbGeAlD
Rasagiline—MAOB—central nervous system—epilepsy syndrome	0.00023	0.0246	CbGeAlD
Rasagiline—MAOB—cerebellum—epilepsy syndrome	0.000224	0.024	CbGeAlD
Rasagiline—MAOB—brain—epilepsy syndrome	0.000182	0.0195	CbGeAlD
Rasagiline—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	4.76e-05	0.000975	CbGpPWpGaD
Rasagiline—BCL2—Ceramide signaling pathway—AKT1—epilepsy syndrome	4.76e-05	0.000974	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GAMT—epilepsy syndrome	4.75e-05	0.000972	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—NHLRC1—epilepsy syndrome	4.75e-05	0.000972	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—EPM2A—epilepsy syndrome	4.75e-05	0.000972	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PNPO—epilepsy syndrome	4.75e-05	0.000972	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL1B—epilepsy syndrome	4.71e-05	0.000964	CbGpPWpGaD
Rasagiline—BCL2—IL-3 Signaling Pathway—AKT1—epilepsy syndrome	4.68e-05	0.000958	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CASP2—epilepsy syndrome	4.65e-05	0.000952	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—CASP8—epilepsy syndrome	4.64e-05	0.00095	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—JUN—epilepsy syndrome	4.56e-05	0.000934	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—CASP8—epilepsy syndrome	4.54e-05	0.000931	CbGpPWpGaD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—AKT1—epilepsy syndrome	4.53e-05	0.000928	CbGpPWpGaD
Rasagiline—BCL2—Immune System—P2RX7—epilepsy syndrome	4.52e-05	0.000926	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—KDR—epilepsy syndrome	4.5e-05	0.000922	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—JUN—epilepsy syndrome	4.43e-05	0.000907	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CA4—epilepsy syndrome	4.41e-05	0.000904	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—QDPR—epilepsy syndrome	4.41e-05	0.000904	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	4.4e-05	0.000902	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—POMC—epilepsy syndrome	4.4e-05	0.000901	CbGpPWpGaD
Rasagiline—CYP1A2—Tryptophan metabolism—CAT—epilepsy syndrome	4.38e-05	0.000897	CbGpPWpGaD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	4.36e-05	0.000893	CbGpPWpGaD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	4.33e-05	0.000888	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—MAPK10—epilepsy syndrome	4.18e-05	0.000856	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—epilepsy syndrome	4.16e-05	0.000852	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—COX3—epilepsy syndrome	4.15e-05	0.00085	CbGpPWpGaD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—AKT1—epilepsy syndrome	4.14e-05	0.000849	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—SRC—epilepsy syndrome	4.09e-05	0.000838	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TNF—epilepsy syndrome	4.08e-05	0.000836	CbGpPWpGaD
Rasagiline—BCL2—Kit receptor signaling pathway—AKT1—epilepsy syndrome	4.03e-05	0.000826	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PFKL—epilepsy syndrome	3.93e-05	0.000805	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—KCNB1—epilepsy syndrome	3.93e-05	0.000805	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CACNA2D2—epilepsy syndrome	3.93e-05	0.000805	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—SLCO1A2—epilepsy syndrome	3.93e-05	0.000805	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—SLC6A8—epilepsy syndrome	3.93e-05	0.000805	CbGpPWpGaD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	3.91e-05	0.000801	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	3.84e-05	0.000787	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—MTOR—epilepsy syndrome	3.82e-05	0.000782	CbGpPWpGaD
Rasagiline—CYP1A2—Arachidonic acid metabolism—GPX1—epilepsy syndrome	3.71e-05	0.000759	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—ACTB—epilepsy syndrome	3.65e-05	0.000747	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—JUN—epilepsy syndrome	3.62e-05	0.000742	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—NEU1—epilepsy syndrome	3.6e-05	0.000737	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ATIC—epilepsy syndrome	3.6e-05	0.000737	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—UPB1—epilepsy syndrome	3.6e-05	0.000737	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—CASP3—epilepsy syndrome	3.51e-05	0.000719	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	3.47e-05	0.000712	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—HSD17B4—epilepsy syndrome	3.46e-05	0.000709	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—CASP3—epilepsy syndrome	3.44e-05	0.000704	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—JUN—epilepsy syndrome	3.41e-05	0.000698	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GBE1—epilepsy syndrome	3.34e-05	0.000685	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PPP1R3C—epilepsy syndrome	3.34e-05	0.000685	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CASP1—epilepsy syndrome	3.31e-05	0.000678	CbGpPWpGaD
Rasagiline—BCL2—Immune System—DUSP4—epilepsy syndrome	3.3e-05	0.000675	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CCR2—epilepsy syndrome	3.22e-05	0.00066	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—DUSP6—epilepsy syndrome	3.19e-05	0.000654	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ASAH1—epilepsy syndrome	3.14e-05	0.000644	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	3.13e-05	0.000642	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—STXBP1—epilepsy syndrome	3.06e-05	0.000626	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—AKT1—epilepsy syndrome	3.04e-05	0.000622	CbGpPWpGaD
Rasagiline—BCL2—Immune System—UBE3A—epilepsy syndrome	3.04e-05	0.000622	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—NT5E—epilepsy syndrome	2.98e-05	0.00061	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ALAD—epilepsy syndrome	2.98e-05	0.00061	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—VEGFA—epilepsy syndrome	2.98e-05	0.00061	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	2.91e-05	0.000596	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CACNA1A—epilepsy syndrome	2.84e-05	0.000582	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ALDH7A1—epilepsy syndrome	2.84e-05	0.000582	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—JUN—epilepsy syndrome	2.84e-05	0.000581	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	2.83e-05	0.000579	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—AKT1—epilepsy syndrome	2.83e-05	0.000579	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—HBEGF—epilepsy syndrome	2.82e-05	0.000577	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ST3GAL3—epilepsy syndrome	2.78e-05	0.00057	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—AKT3—epilepsy syndrome	2.76e-05	0.000566	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ADSL—epilepsy syndrome	2.73e-05	0.000558	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CASP2—epilepsy syndrome	2.71e-05	0.000554	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	2.7e-05	0.000552	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	2.7e-05	0.000552	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GLUL—epilepsy syndrome	2.67e-05	0.000547	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CACNA1D—epilepsy syndrome	2.62e-05	0.000537	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—S100B—epilepsy syndrome	2.55e-05	0.000523	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—SRC—epilepsy syndrome	2.55e-05	0.000521	CbGpPWpGaD
Rasagiline—BCL2—Immune System—EIF2AK2—epilepsy syndrome	2.55e-05	0.000521	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	2.53e-05	0.000519	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CDC42—epilepsy syndrome	2.52e-05	0.000517	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TNF—epilepsy syndrome	2.5e-05	0.000512	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—VEGFA—epilepsy syndrome	2.48e-05	0.000508	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	2.47e-05	0.000506	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—AKT1—epilepsy syndrome	2.47e-05	0.000505	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—TXNRD1—epilepsy syndrome	2.45e-05	0.000503	CbGpPWpGaD
Rasagiline—BCL2—Immune System—MAPK10—epilepsy syndrome	2.43e-05	0.000498	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—RELA—epilepsy syndrome	2.4e-05	0.000492	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PARK2—epilepsy syndrome	2.39e-05	0.00049	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—AQP1—epilepsy syndrome	2.38e-05	0.000488	CbGpPWpGaD
Rasagiline—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	2.36e-05	0.000484	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—epilepsy syndrome	2.33e-05	0.000478	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—CYP2C19—epilepsy syndrome	2.32e-05	0.000474	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—CYP11A1—epilepsy syndrome	2.3e-05	0.000471	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—CYP2C19—epilepsy syndrome	2.28e-05	0.000468	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—CYP11A1—epilepsy syndrome	2.27e-05	0.000465	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—FYN—epilepsy syndrome	2.25e-05	0.00046	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—MEF2C—epilepsy syndrome	2.23e-05	0.000457	CbGpPWpGaD
Rasagiline—CYP1A2—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	2.18e-05	0.000447	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—epilepsy syndrome	2.17e-05	0.000444	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—KCNJ11—epilepsy syndrome	2.15e-05	0.000441	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CHRM3—epilepsy syndrome	2.15e-05	0.000441	CbGpPWpGaD
Rasagiline—BCL2—Immune System—ACTB—epilepsy syndrome	2.12e-05	0.000435	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.12e-05	0.000433	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—epilepsy syndrome	2.1e-05	0.000431	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—CYP2D6—epilepsy syndrome	2.08e-05	0.000426	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.05e-05	0.00042	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	2.04e-05	0.000419	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—TSC2—epilepsy syndrome	1.93e-05	0.000395	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CRP—epilepsy syndrome	1.93e-05	0.000395	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CASP1—epilepsy syndrome	1.93e-05	0.000395	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PTK2B—epilepsy syndrome	1.93e-05	0.000395	CbGpPWpGaD
Rasagiline—Urinary tract disorder—Topiramate—epilepsy syndrome	1.93e-05	0.000127	CcSEcCtD
Rasagiline—Oedema peripheral—Topiramate—epilepsy syndrome	1.92e-05	0.000127	CcSEcCtD
Rasagiline—Hyperhidrosis—Valproic Acid—epilepsy syndrome	1.92e-05	0.000127	CcSEcCtD
Rasagiline—Cough—Pregabalin—epilepsy syndrome	1.92e-05	0.000127	CcSEcCtD
Rasagiline—Pruritus—Phenytoin—epilepsy syndrome	1.92e-05	0.000127	CcSEcCtD
Rasagiline—Connective tissue disorder—Topiramate—epilepsy syndrome	1.92e-05	0.000127	CcSEcCtD
Rasagiline—Nausea—Levetiracetam—epilepsy syndrome	1.92e-05	0.000127	CcSEcCtD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.92e-05	0.000392	CbGpPWpGaD
Rasagiline—Rash—Vigabatrin—epilepsy syndrome	1.92e-05	0.000126	CcSEcCtD
Rasagiline—Dizziness—Felbamate—epilepsy syndrome	1.91e-05	0.000126	CcSEcCtD
Rasagiline—Dermatitis—Vigabatrin—epilepsy syndrome	1.91e-05	0.000126	CcSEcCtD
Rasagiline—Urethral disorder—Topiramate—epilepsy syndrome	1.91e-05	0.000126	CcSEcCtD
Rasagiline—Pruritus—Oxcarbazepine—epilepsy syndrome	1.91e-05	0.000126	CcSEcCtD
Rasagiline—Convulsion—Pregabalin—epilepsy syndrome	1.91e-05	0.000126	CcSEcCtD
Rasagiline—Hypersensitivity—Carbamazepine—epilepsy syndrome	1.91e-05	0.000126	CcSEcCtD
Rasagiline—Headache—Vigabatrin—epilepsy syndrome	1.9e-05	0.000126	CcSEcCtD
Rasagiline—Hypertension—Pregabalin—epilepsy syndrome	1.9e-05	0.000126	CcSEcCtD
Rasagiline—Vomiting—Diazepam—epilepsy syndrome	1.9e-05	0.000126	CcSEcCtD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	1.9e-05	0.000389	CbGpPWpGaD
Rasagiline—Anorexia—Valproic Acid—epilepsy syndrome	1.89e-05	0.000125	CcSEcCtD
Rasagiline—Tremor—Gabapentin—epilepsy syndrome	1.89e-05	0.000125	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—SRC—epilepsy syndrome	1.89e-05	0.000386	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—epilepsy syndrome	1.89e-05	0.000386	CbGpPWpGaD
Rasagiline—Rash—Diazepam—epilepsy syndrome	1.89e-05	0.000125	CcSEcCtD
Rasagiline—Dermatitis—Diazepam—epilepsy syndrome	1.88e-05	0.000124	CcSEcCtD
Rasagiline—BCL2—Immune System—CCR2—epilepsy syndrome	1.88e-05	0.000384	CbGpPWpGaD
Rasagiline—Chest pain—Pregabalin—epilepsy syndrome	1.87e-05	0.000124	CcSEcCtD
Rasagiline—Arthralgia—Pregabalin—epilepsy syndrome	1.87e-05	0.000124	CcSEcCtD
Rasagiline—Ill-defined disorder—Gabapentin—epilepsy syndrome	1.87e-05	0.000124	CcSEcCtD
Rasagiline—Dizziness—Zonisamide—epilepsy syndrome	1.87e-05	0.000124	CcSEcCtD
Rasagiline—Headache—Diazepam—epilepsy syndrome	1.87e-05	0.000124	CcSEcCtD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	1.87e-05	0.000383	CbGpPWpGaD
Rasagiline—Anxiety—Pregabalin—epilepsy syndrome	1.87e-05	0.000123	CcSEcCtD
Rasagiline—BCL2—Immune System—IL1RN—epilepsy syndrome	1.87e-05	0.000383	CbGpPWpGaD
Rasagiline—Diarrhoea—Clonazepam—epilepsy syndrome	1.87e-05	0.000123	CcSEcCtD
Rasagiline—Anaemia—Gabapentin—epilepsy syndrome	1.87e-05	0.000123	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	1.86e-05	0.000123	CcSEcCtD
Rasagiline—BCL2—Apoptosis—AKT1—epilepsy syndrome	1.86e-05	0.000381	CbGpPWpGaD
Rasagiline—BCL2—Immune System—DUSP6—epilepsy syndrome	1.86e-05	0.000381	CbGpPWpGaD
Rasagiline—Hypotension—Valproic Acid—epilepsy syndrome	1.86e-05	0.000123	CcSEcCtD
Rasagiline—Asthenia—Carbamazepine—epilepsy syndrome	1.86e-05	0.000123	CcSEcCtD
Rasagiline—Agitation—Gabapentin—epilepsy syndrome	1.86e-05	0.000123	CcSEcCtD
Rasagiline—Diarrhoea—Phenytoin—epilepsy syndrome	1.86e-05	0.000123	CcSEcCtD
Rasagiline—Discomfort—Pregabalin—epilepsy syndrome	1.85e-05	0.000122	CcSEcCtD
Rasagiline—Nausea—Fosphenytoin—epilepsy syndrome	1.85e-05	0.000122	CcSEcCtD
Rasagiline—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.85e-05	0.000122	CcSEcCtD
Rasagiline—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.84e-05	0.000122	CcSEcCtD
Rasagiline—Vomiting—Felbamate—epilepsy syndrome	1.84e-05	0.000122	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—epilepsy syndrome	1.84e-05	0.000376	CbGpPWpGaD
Rasagiline—Dry mouth—Pregabalin—epilepsy syndrome	1.83e-05	0.000121	CcSEcCtD
Rasagiline—Pruritus—Carbamazepine—epilepsy syndrome	1.83e-05	0.000121	CcSEcCtD
Rasagiline—Rash—Felbamate—epilepsy syndrome	1.82e-05	0.000121	CcSEcCtD
Rasagiline—Eye disorder—Topiramate—epilepsy syndrome	1.82e-05	0.00012	CcSEcCtD
Rasagiline—Dermatitis—Felbamate—epilepsy syndrome	1.82e-05	0.00012	CcSEcCtD
Rasagiline—Malaise—Gabapentin—epilepsy syndrome	1.82e-05	0.00012	CcSEcCtD
Rasagiline—Vertigo—Gabapentin—epilepsy syndrome	1.81e-05	0.00012	CcSEcCtD
Rasagiline—Headache—Felbamate—epilepsy syndrome	1.81e-05	0.00012	CcSEcCtD
Rasagiline—Confusional state—Pregabalin—epilepsy syndrome	1.81e-05	0.00012	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.81e-05	0.00012	CcSEcCtD
Rasagiline—Cardiac disorder—Topiramate—epilepsy syndrome	1.81e-05	0.00012	CcSEcCtD
Rasagiline—Syncope—Gabapentin—epilepsy syndrome	1.81e-05	0.00012	CcSEcCtD
Rasagiline—Leukopenia—Gabapentin—epilepsy syndrome	1.81e-05	0.000119	CcSEcCtD
Rasagiline—Dizziness—Clonazepam—epilepsy syndrome	1.81e-05	0.000119	CcSEcCtD
Rasagiline—Nausea—Vigabatrin—epilepsy syndrome	1.8e-05	0.000119	CcSEcCtD
Rasagiline—Vomiting—Zonisamide—epilepsy syndrome	1.8e-05	0.000119	CcSEcCtD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	1.8e-05	0.000368	CbGpPWpGaD
Rasagiline—Insomnia—Valproic Acid—epilepsy syndrome	1.8e-05	0.000119	CcSEcCtD
Rasagiline—Asthenia—Lamotrigine—epilepsy syndrome	1.79e-05	0.000119	CcSEcCtD
Rasagiline—Dizziness—Phenytoin—epilepsy syndrome	1.79e-05	0.000118	CcSEcCtD
Rasagiline—Rash—Zonisamide—epilepsy syndrome	1.79e-05	0.000118	CcSEcCtD
Rasagiline—Infection—Pregabalin—epilepsy syndrome	1.79e-05	0.000118	CcSEcCtD
Rasagiline—Paraesthesia—Valproic Acid—epilepsy syndrome	1.79e-05	0.000118	CcSEcCtD
Rasagiline—Dermatitis—Zonisamide—epilepsy syndrome	1.78e-05	0.000118	CcSEcCtD
Rasagiline—Dizziness—Oxcarbazepine—epilepsy syndrome	1.78e-05	0.000118	CcSEcCtD
Rasagiline—Nausea—Diazepam—epilepsy syndrome	1.78e-05	0.000117	CcSEcCtD
Rasagiline—Loss of consciousness—Gabapentin—epilepsy syndrome	1.77e-05	0.000117	CcSEcCtD
Rasagiline—Headache—Zonisamide—epilepsy syndrome	1.77e-05	0.000117	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—IL6ST—epilepsy syndrome	1.77e-05	0.000363	CbGpPWpGaD
Rasagiline—Dyspnoea—Valproic Acid—epilepsy syndrome	1.77e-05	0.000117	CcSEcCtD
Rasagiline—Diarrhoea—Carbamazepine—epilepsy syndrome	1.77e-05	0.000117	CcSEcCtD
Rasagiline—Angiopathy—Topiramate—epilepsy syndrome	1.77e-05	0.000117	CcSEcCtD
Rasagiline—Pruritus—Lamotrigine—epilepsy syndrome	1.77e-05	0.000117	CcSEcCtD
Rasagiline—Shock—Pregabalin—epilepsy syndrome	1.77e-05	0.000117	CcSEcCtD
Rasagiline—Somnolence—Valproic Acid—epilepsy syndrome	1.77e-05	0.000117	CcSEcCtD
Rasagiline—Immune system disorder—Topiramate—epilepsy syndrome	1.76e-05	0.000116	CcSEcCtD
Rasagiline—Nervous system disorder—Pregabalin—epilepsy syndrome	1.76e-05	0.000116	CcSEcCtD
Rasagiline—Cough—Gabapentin—epilepsy syndrome	1.76e-05	0.000116	CcSEcCtD
Rasagiline—Mediastinal disorder—Topiramate—epilepsy syndrome	1.76e-05	0.000116	CcSEcCtD
Rasagiline—MAOB—Metabolism—ABCG2—epilepsy syndrome	1.76e-05	0.00036	CbGpPWpGaD
Rasagiline—Chills—Topiramate—epilepsy syndrome	1.75e-05	0.000116	CcSEcCtD
Rasagiline—Dyspepsia—Valproic Acid—epilepsy syndrome	1.75e-05	0.000116	CcSEcCtD
Rasagiline—Convulsion—Gabapentin—epilepsy syndrome	1.75e-05	0.000116	CcSEcCtD
Rasagiline—Skin disorder—Pregabalin—epilepsy syndrome	1.75e-05	0.000115	CcSEcCtD
Rasagiline—BCL2—Immune System—CD40—epilepsy syndrome	1.74e-05	0.000357	CbGpPWpGaD
Rasagiline—Hypertension—Gabapentin—epilepsy syndrome	1.74e-05	0.000115	CcSEcCtD
Rasagiline—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.74e-05	0.000115	CcSEcCtD
Rasagiline—Vomiting—Clonazepam—epilepsy syndrome	1.74e-05	0.000115	CcSEcCtD
Rasagiline—Decreased appetite—Valproic Acid—epilepsy syndrome	1.73e-05	0.000114	CcSEcCtD
Rasagiline—Alopecia—Topiramate—epilepsy syndrome	1.72e-05	0.000114	CcSEcCtD
Rasagiline—Vomiting—Phenytoin—epilepsy syndrome	1.72e-05	0.000114	CcSEcCtD
Rasagiline—Rash—Clonazepam—epilepsy syndrome	1.72e-05	0.000114	CcSEcCtD
Rasagiline—Dermatitis—Clonazepam—epilepsy syndrome	1.72e-05	0.000114	CcSEcCtD
Rasagiline—Arthralgia—Gabapentin—epilepsy syndrome	1.72e-05	0.000114	CcSEcCtD
Rasagiline—Chest pain—Gabapentin—epilepsy syndrome	1.72e-05	0.000114	CcSEcCtD
Rasagiline—Nausea—Felbamate—epilepsy syndrome	1.72e-05	0.000114	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.72e-05	0.000113	CcSEcCtD
Rasagiline—Vomiting—Oxcarbazepine—epilepsy syndrome	1.72e-05	0.000113	CcSEcCtD
Rasagiline—Anxiety—Gabapentin—epilepsy syndrome	1.71e-05	0.000113	CcSEcCtD
Rasagiline—Anorexia—Pregabalin—epilepsy syndrome	1.71e-05	0.000113	CcSEcCtD
Rasagiline—MAOB—Metabolism—CYP2C19—epilepsy syndrome	1.71e-05	0.000351	CbGpPWpGaD
Rasagiline—Dizziness—Carbamazepine—epilepsy syndrome	1.71e-05	0.000113	CcSEcCtD
Rasagiline—Diarrhoea—Lamotrigine—epilepsy syndrome	1.71e-05	0.000113	CcSEcCtD
Rasagiline—Headache—Clonazepam—epilepsy syndrome	1.71e-05	0.000113	CcSEcCtD
Rasagiline—Rash—Phenytoin—epilepsy syndrome	1.71e-05	0.000113	CcSEcCtD
Rasagiline—Mental disorder—Topiramate—epilepsy syndrome	1.71e-05	0.000113	CcSEcCtD
Rasagiline—Dermatitis—Phenytoin—epilepsy syndrome	1.71e-05	0.000113	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.71e-05	0.000113	CcSEcCtD
Rasagiline—MAOB—Metabolism—CYP11A1—epilepsy syndrome	1.7e-05	0.000348	CbGpPWpGaD
Rasagiline—Rash—Oxcarbazepine—epilepsy syndrome	1.7e-05	0.000112	CcSEcCtD
Rasagiline—Constipation—Valproic Acid—epilepsy syndrome	1.7e-05	0.000112	CcSEcCtD
Rasagiline—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.7e-05	0.000112	CcSEcCtD
Rasagiline—Headache—Phenytoin—epilepsy syndrome	1.7e-05	0.000112	CcSEcCtD
Rasagiline—Malnutrition—Topiramate—epilepsy syndrome	1.7e-05	0.000112	CcSEcCtD
Rasagiline—Discomfort—Gabapentin—epilepsy syndrome	1.7e-05	0.000112	CcSEcCtD
Rasagiline—Headache—Oxcarbazepine—epilepsy syndrome	1.69e-05	0.000112	CcSEcCtD
Rasagiline—Nausea—Zonisamide—epilepsy syndrome	1.68e-05	0.000111	CcSEcCtD
Rasagiline—Dry mouth—Gabapentin—epilepsy syndrome	1.68e-05	0.000111	CcSEcCtD
Rasagiline—Hypotension—Pregabalin—epilepsy syndrome	1.68e-05	0.000111	CcSEcCtD
Rasagiline—Flatulence—Topiramate—epilepsy syndrome	1.67e-05	0.000111	CcSEcCtD
Rasagiline—Dysgeusia—Topiramate—epilepsy syndrome	1.66e-05	0.00011	CcSEcCtD
Rasagiline—Confusional state—Gabapentin—epilepsy syndrome	1.66e-05	0.00011	CcSEcCtD
Rasagiline—Dizziness—Lamotrigine—epilepsy syndrome	1.65e-05	0.000109	CcSEcCtD
Rasagiline—Vomiting—Carbamazepine—epilepsy syndrome	1.65e-05	0.000109	CcSEcCtD
Rasagiline—Back pain—Topiramate—epilepsy syndrome	1.64e-05	0.000109	CcSEcCtD
Rasagiline—BCL2—Immune System—HBEGF—epilepsy syndrome	1.64e-05	0.000336	CbGpPWpGaD
Rasagiline—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.64e-05	0.000108	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.64e-05	0.000108	CcSEcCtD
Rasagiline—Infection—Gabapentin—epilepsy syndrome	1.64e-05	0.000108	CcSEcCtD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	1.63e-05	0.000335	CbGpPWpGaD
Rasagiline—Muscle spasms—Topiramate—epilepsy syndrome	1.63e-05	0.000108	CcSEcCtD
Rasagiline—Rash—Carbamazepine—epilepsy syndrome	1.63e-05	0.000108	CcSEcCtD
Rasagiline—Dermatitis—Carbamazepine—epilepsy syndrome	1.63e-05	0.000108	CcSEcCtD
Rasagiline—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.63e-05	0.000107	CcSEcCtD
Rasagiline—Insomnia—Pregabalin—epilepsy syndrome	1.63e-05	0.000107	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—FOS—epilepsy syndrome	1.63e-05	0.000333	CbGpPWpGaD
Rasagiline—Nausea—Clonazepam—epilepsy syndrome	1.62e-05	0.000107	CcSEcCtD
Rasagiline—Headache—Carbamazepine—epilepsy syndrome	1.62e-05	0.000107	CcSEcCtD
Rasagiline—Shock—Gabapentin—epilepsy syndrome	1.62e-05	0.000107	CcSEcCtD
Rasagiline—Nervous system disorder—Gabapentin—epilepsy syndrome	1.62e-05	0.000107	CcSEcCtD
Rasagiline—Paraesthesia—Pregabalin—epilepsy syndrome	1.61e-05	0.000107	CcSEcCtD
Rasagiline—Nausea—Phenytoin—epilepsy syndrome	1.61e-05	0.000106	CcSEcCtD
Rasagiline—BCL2—Immune System—AKT3—epilepsy syndrome	1.61e-05	0.00033	CbGpPWpGaD
Rasagiline—Dyspnoea—Pregabalin—epilepsy syndrome	1.6e-05	0.000106	CcSEcCtD
Rasagiline—Nausea—Oxcarbazepine—epilepsy syndrome	1.6e-05	0.000106	CcSEcCtD
Rasagiline—Skin disorder—Gabapentin—epilepsy syndrome	1.6e-05	0.000106	CcSEcCtD
Rasagiline—Somnolence—Pregabalin—epilepsy syndrome	1.6e-05	0.000106	CcSEcCtD
Rasagiline—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.59e-05	0.000105	CcSEcCtD
Rasagiline—Tremor—Topiramate—epilepsy syndrome	1.59e-05	0.000105	CcSEcCtD
Rasagiline—Vomiting—Lamotrigine—epilepsy syndrome	1.59e-05	0.000105	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—CASP8—epilepsy syndrome	1.59e-05	0.000325	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CA13—epilepsy syndrome	1.58e-05	0.000325	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—AKT1—epilepsy syndrome	1.58e-05	0.000324	CbGpPWpGaD
Rasagiline—Urticaria—Valproic Acid—epilepsy syndrome	1.58e-05	0.000104	CcSEcCtD
Rasagiline—Rash—Lamotrigine—epilepsy syndrome	1.58e-05	0.000104	CcSEcCtD
Rasagiline—Ill-defined disorder—Topiramate—epilepsy syndrome	1.58e-05	0.000104	CcSEcCtD
Rasagiline—Dermatitis—Lamotrigine—epilepsy syndrome	1.58e-05	0.000104	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.58e-05	0.000323	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	1.57e-05	0.000322	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	1.57e-05	0.000322	CbGpPWpGaD
Rasagiline—Body temperature increased—Valproic Acid—epilepsy syndrome	1.57e-05	0.000104	CcSEcCtD
Rasagiline—Abdominal pain—Valproic Acid—epilepsy syndrome	1.57e-05	0.000104	CcSEcCtD
Rasagiline—Anorexia—Gabapentin—epilepsy syndrome	1.57e-05	0.000104	CcSEcCtD
Rasagiline—Anaemia—Topiramate—epilepsy syndrome	1.57e-05	0.000104	CcSEcCtD
Rasagiline—Headache—Lamotrigine—epilepsy syndrome	1.57e-05	0.000103	CcSEcCtD
Rasagiline—Decreased appetite—Pregabalin—epilepsy syndrome	1.56e-05	0.000103	CcSEcCtD
Rasagiline—Agitation—Topiramate—epilepsy syndrome	1.56e-05	0.000103	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.55e-05	0.000102	CcSEcCtD
Rasagiline—Hypotension—Gabapentin—epilepsy syndrome	1.54e-05	0.000102	CcSEcCtD
Rasagiline—Nausea—Carbamazepine—epilepsy syndrome	1.54e-05	0.000102	CcSEcCtD
Rasagiline—Constipation—Pregabalin—epilepsy syndrome	1.54e-05	0.000101	CcSEcCtD
Rasagiline—MAOB—Metabolism—CYP2D6—epilepsy syndrome	1.54e-05	0.000314	CbGpPWpGaD
Rasagiline—Malaise—Topiramate—epilepsy syndrome	1.53e-05	0.000101	CcSEcCtD
Rasagiline—Vertigo—Topiramate—epilepsy syndrome	1.53e-05	0.000101	CcSEcCtD
Rasagiline—Syncope—Topiramate—epilepsy syndrome	1.52e-05	0.000101	CcSEcCtD
Rasagiline—Leukopenia—Topiramate—epilepsy syndrome	1.52e-05	0.0001	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.5e-05	9.92e-05	CcSEcCtD
Rasagiline—Loss of consciousness—Topiramate—epilepsy syndrome	1.49e-05	9.86e-05	CcSEcCtD
Rasagiline—Insomnia—Gabapentin—epilepsy syndrome	1.49e-05	9.84e-05	CcSEcCtD
Rasagiline—BCL2—Immune System—S100B—epilepsy syndrome	1.49e-05	0.000305	CbGpPWpGaD
Rasagiline—Nausea—Lamotrigine—epilepsy syndrome	1.49e-05	9.81e-05	CcSEcCtD
Rasagiline—Cough—Topiramate—epilepsy syndrome	1.48e-05	9.79e-05	CcSEcCtD
Rasagiline—Feeling abnormal—Pregabalin—epilepsy syndrome	1.48e-05	9.78e-05	CcSEcCtD
Rasagiline—Paraesthesia—Gabapentin—epilepsy syndrome	1.48e-05	9.77e-05	CcSEcCtD
Rasagiline—BCL2—Immune System—SOCS3—epilepsy syndrome	1.47e-05	0.000302	CbGpPWpGaD
Rasagiline—Convulsion—Topiramate—epilepsy syndrome	1.47e-05	9.72e-05	CcSEcCtD
Rasagiline—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.47e-05	9.71e-05	CcSEcCtD
Rasagiline—Dyspnoea—Gabapentin—epilepsy syndrome	1.47e-05	9.7e-05	CcSEcCtD
Rasagiline—BCL2—Immune System—CDC42—epilepsy syndrome	1.47e-05	0.000301	CbGpPWpGaD
Rasagiline—Hypertension—Topiramate—epilepsy syndrome	1.47e-05	9.69e-05	CcSEcCtD
Rasagiline—Somnolence—Gabapentin—epilepsy syndrome	1.47e-05	9.68e-05	CcSEcCtD
Rasagiline—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.46e-05	9.67e-05	CcSEcCtD
Rasagiline—MAOB—Metabolism—ADRA2A—epilepsy syndrome	1.46e-05	0.000299	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—BCHE—epilepsy syndrome	1.46e-05	0.000298	CbGpPWpGaD
Rasagiline—Dyspepsia—Gabapentin—epilepsy syndrome	1.45e-05	9.58e-05	CcSEcCtD
Rasagiline—Arthralgia—Topiramate—epilepsy syndrome	1.45e-05	9.55e-05	CcSEcCtD
Rasagiline—Chest pain—Topiramate—epilepsy syndrome	1.45e-05	9.55e-05	CcSEcCtD
Rasagiline—Anxiety—Topiramate—epilepsy syndrome	1.44e-05	9.52e-05	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.44e-05	9.49e-05	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—FGF2—epilepsy syndrome	1.43e-05	0.000294	CbGpPWpGaD
Rasagiline—Decreased appetite—Gabapentin—epilepsy syndrome	1.43e-05	9.46e-05	CcSEcCtD
Rasagiline—Discomfort—Topiramate—epilepsy syndrome	1.43e-05	9.44e-05	CcSEcCtD
Rasagiline—Urticaria—Pregabalin—epilepsy syndrome	1.43e-05	9.43e-05	CcSEcCtD
Rasagiline—Asthenia—Valproic Acid—epilepsy syndrome	1.43e-05	9.42e-05	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.42e-05	9.4e-05	CcSEcCtD
Rasagiline—Body temperature increased—Pregabalin—epilepsy syndrome	1.42e-05	9.38e-05	CcSEcCtD
Rasagiline—Abdominal pain—Pregabalin—epilepsy syndrome	1.42e-05	9.38e-05	CcSEcCtD
Rasagiline—Dry mouth—Topiramate—epilepsy syndrome	1.41e-05	9.34e-05	CcSEcCtD
Rasagiline—Constipation—Gabapentin—epilepsy syndrome	1.41e-05	9.31e-05	CcSEcCtD
Rasagiline—Pruritus—Valproic Acid—epilepsy syndrome	1.41e-05	9.29e-05	CcSEcCtD
Rasagiline—Confusional state—Topiramate—epilepsy syndrome	1.4e-05	9.23e-05	CcSEcCtD
Rasagiline—MAOB—Metabolism—SLC2A1—epilepsy syndrome	1.39e-05	0.000284	CbGpPWpGaD
Rasagiline—Infection—Topiramate—epilepsy syndrome	1.38e-05	9.1e-05	CcSEcCtD
Rasagiline—MAOB—Metabolism—PLCB1—epilepsy syndrome	1.37e-05	0.000281	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—TH—epilepsy syndrome	1.37e-05	0.00028	CbGpPWpGaD
Rasagiline—Shock—Topiramate—epilepsy syndrome	1.36e-05	9.01e-05	CcSEcCtD
Rasagiline—Diarrhoea—Valproic Acid—epilepsy syndrome	1.36e-05	8.98e-05	CcSEcCtD
Rasagiline—Nervous system disorder—Topiramate—epilepsy syndrome	1.36e-05	8.98e-05	CcSEcCtD
Rasagiline—Feeling abnormal—Gabapentin—epilepsy syndrome	1.36e-05	8.97e-05	CcSEcCtD
Rasagiline—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.35e-05	8.9e-05	CcSEcCtD
Rasagiline—Skin disorder—Topiramate—epilepsy syndrome	1.35e-05	8.89e-05	CcSEcCtD
Rasagiline—BCL2—Immune System—IL18—epilepsy syndrome	1.34e-05	0.000275	CbGpPWpGaD
Rasagiline—Hyperhidrosis—Topiramate—epilepsy syndrome	1.34e-05	8.85e-05	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—RELA—epilepsy syndrome	1.33e-05	0.000273	CbGpPWpGaD
Rasagiline—Hypersensitivity—Pregabalin—epilepsy syndrome	1.32e-05	8.74e-05	CcSEcCtD
Rasagiline—Anorexia—Topiramate—epilepsy syndrome	1.32e-05	8.73e-05	CcSEcCtD
Rasagiline—Dizziness—Valproic Acid—epilepsy syndrome	1.31e-05	8.68e-05	CcSEcCtD
Rasagiline—Urticaria—Gabapentin—epilepsy syndrome	1.31e-05	8.65e-05	CcSEcCtD
Rasagiline—BCL2—Immune System—FYN—epilepsy syndrome	1.31e-05	0.000268	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—MTOR—epilepsy syndrome	1.31e-05	0.000268	CbGpPWpGaD
Rasagiline—Abdominal pain—Gabapentin—epilepsy syndrome	1.3e-05	8.6e-05	CcSEcCtD
Rasagiline—Body temperature increased—Gabapentin—epilepsy syndrome	1.3e-05	8.6e-05	CcSEcCtD
Rasagiline—BCL2—Immune System—MEF2C—epilepsy syndrome	1.3e-05	0.000266	CbGpPWpGaD
Rasagiline—Hypotension—Topiramate—epilepsy syndrome	1.3e-05	8.56e-05	CcSEcCtD
Rasagiline—Asthenia—Pregabalin—epilepsy syndrome	1.29e-05	8.52e-05	CcSEcCtD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.28e-05	0.000261	CbGpPWpGaD
Rasagiline—Pruritus—Pregabalin—epilepsy syndrome	1.27e-05	8.4e-05	CcSEcCtD
Rasagiline—Vomiting—Valproic Acid—epilepsy syndrome	1.26e-05	8.35e-05	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.26e-05	8.34e-05	CcSEcCtD
Rasagiline—BCL2—Immune System—YWHAZ—epilepsy syndrome	1.26e-05	0.000257	CbGpPWpGaD
Rasagiline—Insomnia—Topiramate—epilepsy syndrome	1.25e-05	8.28e-05	CcSEcCtD
Rasagiline—Rash—Valproic Acid—epilepsy syndrome	1.25e-05	8.28e-05	CcSEcCtD
Rasagiline—Dermatitis—Valproic Acid—epilepsy syndrome	1.25e-05	8.27e-05	CcSEcCtD
Rasagiline—Headache—Valproic Acid—epilepsy syndrome	1.25e-05	8.22e-05	CcSEcCtD
Rasagiline—Paraesthesia—Topiramate—epilepsy syndrome	1.25e-05	8.22e-05	CcSEcCtD
Rasagiline—Dyspnoea—Topiramate—epilepsy syndrome	1.24e-05	8.16e-05	CcSEcCtD
Rasagiline—Somnolence—Topiramate—epilepsy syndrome	1.23e-05	8.14e-05	CcSEcCtD
Rasagiline—Diarrhoea—Pregabalin—epilepsy syndrome	1.23e-05	8.12e-05	CcSEcCtD
Rasagiline—Dyspepsia—Topiramate—epilepsy syndrome	1.22e-05	8.06e-05	CcSEcCtD
Rasagiline—Hypersensitivity—Gabapentin—epilepsy syndrome	1.21e-05	8.02e-05	CcSEcCtD
Rasagiline—Decreased appetite—Topiramate—epilepsy syndrome	1.21e-05	7.96e-05	CcSEcCtD
Rasagiline—CYP1A2—Metabolism—FAR1—epilepsy syndrome	1.2e-05	0.000246	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CERS1—epilepsy syndrome	1.2e-05	0.000246	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—L2HGDH—epilepsy syndrome	1.2e-05	0.000246	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ADK—epilepsy syndrome	1.2e-05	0.000246	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GLUD1—epilepsy syndrome	1.2e-05	0.000246	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PDXK—epilepsy syndrome	1.2e-05	0.000246	CbGpPWpGaD
Rasagiline—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.2e-05	7.9e-05	CcSEcCtD
Rasagiline—Dizziness—Pregabalin—epilepsy syndrome	1.19e-05	7.85e-05	CcSEcCtD
Rasagiline—Constipation—Topiramate—epilepsy syndrome	1.19e-05	7.83e-05	CcSEcCtD
Rasagiline—Asthenia—Gabapentin—epilepsy syndrome	1.18e-05	7.81e-05	CcSEcCtD
Rasagiline—Nausea—Valproic Acid—epilepsy syndrome	1.18e-05	7.8e-05	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—JUN—epilepsy syndrome	1.17e-05	0.000239	CbGpPWpGaD
Rasagiline—Pruritus—Gabapentin—epilepsy syndrome	1.17e-05	7.7e-05	CcSEcCtD
Rasagiline—Vomiting—Pregabalin—epilepsy syndrome	1.14e-05	7.55e-05	CcSEcCtD
Rasagiline—Feeling abnormal—Topiramate—epilepsy syndrome	1.14e-05	7.55e-05	CcSEcCtD
Rasagiline—MAOB—Metabolism—HMOX1—epilepsy syndrome	1.14e-05	0.000234	CbGpPWpGaD
Rasagiline—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.13e-05	7.49e-05	CcSEcCtD
Rasagiline—Rash—Pregabalin—epilepsy syndrome	1.13e-05	7.48e-05	CcSEcCtD
Rasagiline—Dermatitis—Pregabalin—epilepsy syndrome	1.13e-05	7.48e-05	CcSEcCtD
Rasagiline—Diarrhoea—Gabapentin—epilepsy syndrome	1.13e-05	7.45e-05	CcSEcCtD
Rasagiline—MAOB—Metabolism—CAT—epilepsy syndrome	1.13e-05	0.000231	CbGpPWpGaD
Rasagiline—Headache—Pregabalin—epilepsy syndrome	1.13e-05	7.44e-05	CcSEcCtD
Rasagiline—BCL2—Immune System—TSC2—epilepsy syndrome	1.12e-05	0.00023	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CRP—epilepsy syndrome	1.12e-05	0.00023	CbGpPWpGaD
Rasagiline—Urticaria—Topiramate—epilepsy syndrome	1.1e-05	7.27e-05	CcSEcCtD
Rasagiline—CYP1A2—Metabolism—GAMT—epilepsy syndrome	1.1e-05	0.000225	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PNPO—epilepsy syndrome	1.1e-05	0.000225	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	1.1e-05	0.000225	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	1.1e-05	0.000225	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ABCB1—epilepsy syndrome	1.1e-05	0.000225	CbGpPWpGaD
Rasagiline—Body temperature increased—Topiramate—epilepsy syndrome	1.1e-05	7.24e-05	CcSEcCtD
Rasagiline—Abdominal pain—Topiramate—epilepsy syndrome	1.1e-05	7.24e-05	CcSEcCtD
Rasagiline—Dizziness—Gabapentin—epilepsy syndrome	1.09e-05	7.2e-05	CcSEcCtD
Rasagiline—Nausea—Pregabalin—epilepsy syndrome	1.07e-05	7.05e-05	CcSEcCtD
Rasagiline—Vomiting—Gabapentin—epilepsy syndrome	1.05e-05	6.92e-05	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—SRC—epilepsy syndrome	1.05e-05	0.000214	CbGpPWpGaD
Rasagiline—Rash—Gabapentin—epilepsy syndrome	1.04e-05	6.86e-05	CcSEcCtD
Rasagiline—Dermatitis—Gabapentin—epilepsy syndrome	1.04e-05	6.86e-05	CcSEcCtD
Rasagiline—BCL2—Immune System—PRKCB—epilepsy syndrome	1.04e-05	0.000212	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL6ST—epilepsy syndrome	1.03e-05	0.000212	CbGpPWpGaD
Rasagiline—Headache—Gabapentin—epilepsy syndrome	1.03e-05	6.82e-05	CcSEcCtD
Rasagiline—Hypersensitivity—Topiramate—epilepsy syndrome	1.02e-05	6.75e-05	CcSEcCtD
Rasagiline—CYP1A2—Metabolism—QDPR—epilepsy syndrome	1.02e-05	0.000209	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CA4—epilepsy syndrome	1.02e-05	0.000209	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GPX1—epilepsy syndrome	1.02e-05	0.000209	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	1.02e-05	0.000208	CbGpPWpGaD
Rasagiline—Asthenia—Topiramate—epilepsy syndrome	9.95e-06	6.57e-05	CcSEcCtD
Rasagiline—Pruritus—Topiramate—epilepsy syndrome	9.81e-06	6.48e-05	CcSEcCtD
Rasagiline—Nausea—Gabapentin—epilepsy syndrome	9.79e-06	6.46e-05	CcSEcCtD
Rasagiline—CYP1A2—Metabolism—COX3—epilepsy syndrome	9.6e-06	0.000197	CbGpPWpGaD
Rasagiline—Diarrhoea—Topiramate—epilepsy syndrome	9.49e-06	6.26e-05	CcSEcCtD
Rasagiline—BCL2—Immune System—FOS—epilepsy syndrome	9.47e-06	0.000194	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CASP8—epilepsy syndrome	9.25e-06	0.000189	CbGpPWpGaD
Rasagiline—Dizziness—Topiramate—epilepsy syndrome	9.17e-06	6.05e-05	CcSEcCtD
Rasagiline—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	9.1e-06	0.000186	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	9.1e-06	0.000186	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	9.1e-06	0.000186	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PFKL—epilepsy syndrome	9.1e-06	0.000186	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	9.1e-06	0.000186	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—AGT—epilepsy syndrome	8.94e-06	0.000183	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	8.9e-06	0.000182	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	8.84e-06	0.000181	CbGpPWpGaD
Rasagiline—Vomiting—Topiramate—epilepsy syndrome	8.82e-06	5.82e-05	CcSEcCtD
Rasagiline—MAOB—Metabolism—APOE—epilepsy syndrome	8.76e-06	0.000179	CbGpPWpGaD
Rasagiline—Rash—Topiramate—epilepsy syndrome	8.74e-06	5.77e-05	CcSEcCtD
Rasagiline—Dermatitis—Topiramate—epilepsy syndrome	8.73e-06	5.77e-05	CcSEcCtD
Rasagiline—Headache—Topiramate—epilepsy syndrome	8.69e-06	5.74e-05	CcSEcCtD
Rasagiline—BCL2—Immune System—FGF2—epilepsy syndrome	8.36e-06	0.000171	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—UPB1—epilepsy syndrome	8.32e-06	0.00017	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NEU1—epilepsy syndrome	8.32e-06	0.00017	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ATIC—epilepsy syndrome	8.32e-06	0.00017	CbGpPWpGaD
Rasagiline—Nausea—Topiramate—epilepsy syndrome	8.24e-06	5.44e-05	CcSEcCtD
Rasagiline—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	8.01e-06	0.000164	CbGpPWpGaD
Rasagiline—BCL2—Immune System—RELA—epilepsy syndrome	7.76e-06	0.000159	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GBE1—epilepsy syndrome	7.74e-06	0.000158	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	7.74e-06	0.000158	CbGpPWpGaD
Rasagiline—BCL2—Immune System—MTOR—epilepsy syndrome	7.61e-06	0.000156	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	7.56e-06	0.000155	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—POMC—epilepsy syndrome	7.52e-06	0.000154	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	7.28e-06	0.000149	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	7.08e-06	0.000145	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL1B—epilepsy syndrome	7.01e-06	0.000144	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NT5E—epilepsy syndrome	6.9e-06	0.000141	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ALAD—epilepsy syndrome	6.9e-06	0.000141	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ALB—epilepsy syndrome	6.86e-06	0.00014	CbGpPWpGaD
Rasagiline—BCL2—Immune System—JUN—epilepsy syndrome	6.8e-06	0.000139	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	6.58e-06	0.000135	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	6.58e-06	0.000135	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—AKT1—epilepsy syndrome	6.5e-06	0.000133	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	6.44e-06	0.000132	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ADSL—epilepsy syndrome	6.31e-06	0.000129	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GLUL—epilepsy syndrome	6.19e-06	0.000127	CbGpPWpGaD
Rasagiline—BCL2—Immune System—SRC—epilepsy syndrome	6.1e-06	0.000125	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	6.07e-06	0.000124	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PTGS2—epilepsy syndrome	6e-06	0.000123	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	5.68e-06	0.000116	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—AQP1—epilepsy syndrome	5.51e-06	0.000113	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.3e-06	0.000108	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	4.99e-06	0.000102	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	4.99e-06	0.000102	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.64e-06	9.51e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.55e-06	9.32e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	4.07e-06	8.33e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	3.96e-06	8.11e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	3.94e-06	8.06e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.91e-06	8.01e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—AKT1—epilepsy syndrome	3.79e-06	7.76e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.56e-06	7.3e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	3.55e-06	7.28e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	3.38e-06	6.93e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—BCHE—epilepsy syndrome	3.37e-06	6.9e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	3.21e-06	6.58e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	3.18e-06	6.51e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—TH—epilepsy syndrome	3.17e-06	6.49e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.12e-06	6.39e-05	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—AKT1—epilepsy syndrome	3.02e-06	6.18e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	2.64e-06	5.41e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CAT—epilepsy syndrome	2.61e-06	5.34e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	2.54e-06	5.2e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GPX1—epilepsy syndrome	2.36e-06	4.83e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—AGT—epilepsy syndrome	2.07e-06	4.24e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—APOE—epilepsy syndrome	2.03e-06	4.15e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.74e-06	3.57e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.59e-06	3.25e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.39e-06	2.84e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—AKT1—epilepsy syndrome	6.98e-07	1.43e-05	CbGpPWpGaD
